Could high direct bilirubin indicate a bile duct blockage?

High direct bilirubin levels can indeed indicate a bile duct blockage, as this condition prevents the liver from properly excreting bilirubin into the intestines. If your direct bilirubin is elevated, seek medical evaluation promptly to determine the underlying cause and appropriate treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Direct Bilirubin and Its Role in Your Body

Bilirubin is a yellow pigment produced when your body breaks down old red blood cells. This process happens continuously as part of your body's normal recycling system. When red blood cells reach the end of their 120-day lifespan, they're broken down in the spleen and liver, releasing hemoglobin that's converted into bilirubin.

There are two main types of bilirubin in your blood: indirect (unconjugated) and direct (conjugated) bilirubin. Indirect bilirubin is the initial form that's not water-soluble and must be processed by the liver. Once in the liver, it's converted to direct bilirubin, which is water-soluble and can be excreted through bile into the intestines.

Direct bilirubin normally makes up a small fraction of total bilirubin in your blood. When levels rise above normal, it often signals a problem with how your liver is processing or eliminating bilirubin, particularly through the bile ducts. Understanding your bilirubin levels through comprehensive testing can provide crucial insights into your liver and gallbladder health.

Bilirubin Level Interpretation Guide

Bilirubin fractionation helps determine the location and type of liver or biliary dysfunction.
Bilirubin TypeNormal RangeElevated Level IndicatesClinical Significance
Total BilirubinTotal Bilirubin0.3-1.2 mg/dLAny liver or biliary problemScreening marker for jaundice
Direct BilirubinDirect Bilirubin0.0-0.3 mg/dLBile flow obstructionSpecific for post-hepatic issues
Indirect BilirubinIndirect Bilirubin0.2-0.8 mg/dLHemolysis or liver dysfunctionPre-hepatic or hepatic problems
Direct/Total RatioDirect/Total Ratio<20%>50% suggests obstructionHelps differentiate cause of jaundice

Bilirubin fractionation helps determine the location and type of liver or biliary dysfunction.

How Bile Duct Blockages Affect Direct Bilirubin Levels

When bile ducts become blocked, direct bilirubin that should flow from the liver into the intestines backs up into the bloodstream. This backup occurs because the normal drainage pathway is obstructed, preventing the liver from excreting bilirubin properly. As a result, direct bilirubin levels in the blood rise significantly.

The bile duct system is like a network of pipes that carry bile from the liver and gallbladder to the small intestine. When any part of this system becomes blocked, whether in the small intrahepatic ducts within the liver or the larger extrahepatic ducts outside the liver, direct bilirubin accumulates. This accumulation is what makes elevated direct bilirubin such a reliable indicator of bile duct obstruction.

Healthcare providers often look at the ratio of direct to total bilirubin to help determine the cause of jaundice. When direct bilirubin makes up more than 50% of total bilirubin, it strongly suggests a problem with bile flow, such as a blockage. Understanding these patterns helps doctors distinguish between different types of liver and biliary problems.

Common Causes of Bile Duct Blockages

Gallstones and Biliary Obstruction

Gallstones are the most common cause of bile duct blockages. These hardened deposits of digestive fluid can form in the gallbladder and migrate into the bile ducts, causing obstruction. When a gallstone lodges in the common bile duct, it creates a condition called choledocholithiasis, which can cause severe pain, jaundice, and elevated direct bilirubin levels.

Tumors and Malignancies

Both benign and malignant tumors can compress or invade bile ducts, leading to obstruction. Pancreatic cancer, cholangiocarcinoma (bile duct cancer), and tumors of the ampulla of Vater are among the most serious causes. These conditions often present with gradually worsening jaundice and may be accompanied by weight loss, abdominal pain, and other systemic symptoms.

Inflammatory and Autoimmune Conditions

Several inflammatory conditions can cause bile duct blockages. Primary sclerosing cholangitis (PSC) and primary biliary cholangitis (PBC) are autoimmune diseases that cause inflammation and scarring of the bile ducts. Pancreatitis can also lead to bile duct compression due to inflammation of the pancreas. Additionally, infections such as cholangitis can cause swelling and obstruction of the bile ducts.

Recognizing Symptoms of Bile Duct Blockage

The symptoms of bile duct blockage can vary depending on the cause, location, and severity of the obstruction. However, certain signs are particularly common and should prompt immediate medical attention:

  • Jaundice (yellowing of the skin and eyes) - the most visible sign of elevated bilirubin
  • Dark urine that looks like tea or cola due to excess bilirubin being excreted by the kidneys
  • Pale or clay-colored stools from lack of bilirubin reaching the intestines
  • Intense itching (pruritus) caused by bile salt accumulation in the skin
  • Right upper abdominal pain, especially after eating fatty foods
  • Fever and chills if infection is present
  • Unexplained weight loss and loss of appetite
  • Nausea and vomiting

The onset of symptoms can be sudden in cases of gallstone obstruction or gradual in cases of tumors or chronic inflammatory conditions. Some people may experience intermittent symptoms if the blockage is partial or if stones move in and out of the duct. Regular monitoring of liver function markers, including bilirubin levels, can help detect problems early before symptoms become severe.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Tests Beyond Direct Bilirubin

While elevated direct bilirubin is an important indicator of bile duct blockage, doctors typically order additional tests to confirm the diagnosis and identify the underlying cause. A comprehensive liver function panel includes other markers such as alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and aminotransferases (ALT and AST), which can help differentiate between various liver and biliary conditions.

Imaging studies play a crucial role in diagnosing bile duct blockages. Ultrasound is often the first imaging test performed, as it can detect dilated bile ducts and gallstones. More advanced imaging such as MRCP (magnetic resonance cholangiopancreatography) or ERCP (endoscopic retrograde cholangiopancreatography) may be needed to visualize the bile ducts in detail and identify the exact location and cause of obstruction.

Blood tests may also include tumor markers like CA 19-9 if cancer is suspected, or specific antibodies if an autoimmune condition is being considered. The pattern of liver enzyme elevation, combined with bilirubin levels and imaging findings, helps doctors determine whether the blockage is due to stones, tumors, or other causes.

Treatment Options for Bile Duct Blockages

Emergency and Surgical Interventions

Treatment for bile duct blockages depends on the underlying cause and severity. For gallstone-related blockages, ERCP can be both diagnostic and therapeutic, allowing doctors to remove stones and place stents if needed. In some cases, surgery such as cholecystectomy (gallbladder removal) may be necessary to prevent future stone formation.

For tumors causing obstruction, treatment may involve surgical resection if the tumor is operable, or palliative stenting to relieve the blockage if surgery isn't possible. The Whipple procedure (pancreaticoduodenectomy) may be performed for tumors in the head of the pancreas or distal bile duct.

Medical Management and Supportive Care

Medical management focuses on treating symptoms and preventing complications. Ursodeoxycholic acid may be prescribed for certain chronic biliary conditions to improve bile flow. Antibiotics are essential if infection is present. Vitamin supplementation, particularly fat-soluble vitamins (A, D, E, K), may be needed since bile duct blockage impairs fat absorption.

Managing itching from bile salt accumulation often requires medications like cholestyramine or rifampin. Pain management and nutritional support are also important aspects of care. For chronic conditions causing recurrent blockages, long-term monitoring and management strategies are essential.

When to Seek Medical Attention

Certain symptoms warrant immediate medical evaluation. Seek emergency care if you experience sudden severe abdominal pain, high fever with chills, persistent vomiting, or rapidly worsening jaundice. These symptoms could indicate acute cholangitis, a serious infection of the bile ducts that requires urgent treatment.

Even without emergency symptoms, you should consult a healthcare provider if you notice persistent changes in urine or stool color, unexplained itching, or mild jaundice. Early detection and treatment of bile duct problems can prevent serious complications such as liver damage, sepsis, or biliary cirrhosis.

Regular health monitoring, including liver function tests, is particularly important if you have risk factors for bile duct problems such as a history of gallstones, inflammatory bowel disease, or family history of biliary cancers. Tracking your liver health markers over time can help identify trends before they become serious issues.

Living with Chronic Bile Duct Conditions

For those diagnosed with chronic conditions affecting the bile ducts, long-term management becomes essential. This includes regular monitoring of liver function, imaging studies to assess disease progression, and lifestyle modifications to support liver health. Dietary changes such as limiting fat intake during acute episodes and ensuring adequate nutrition are important components of care.

Support groups and patient education resources can be valuable for those dealing with chronic biliary conditions. Understanding your condition, recognizing warning signs of complications, and maintaining open communication with your healthcare team are crucial for optimal outcomes. Many people with properly managed bile duct conditions can maintain good quality of life with appropriate treatment and monitoring.

The Importance of Early Detection

High direct bilirubin levels serve as an important early warning sign of bile duct problems. While not all cases of elevated direct bilirubin indicate a blockage, this finding always warrants further investigation. Early detection of bile duct obstruction can make a significant difference in treatment outcomes, particularly for conditions like bile duct cancer where early intervention improves prognosis.

Regular health screenings that include liver function tests can help catch problems before symptoms develop. This is especially important for individuals with risk factors such as a history of gallstones, chronic liver disease, or family history of biliary cancers. By staying proactive about your liver health and understanding what your lab results mean, you can work with your healthcare provider to address issues promptly and maintain optimal health.

References

  1. Fevery, J. (2008). Bilirubin in clinical practice: a review. Liver International, 28(5), 592-605.[Link][PubMed][DOI]
  2. European Association for the Study of the Liver. (2017). EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. Journal of Hepatology, 67(1), 145-172.[Link][PubMed][DOI]
  3. Qiao, T., Ma, R. H., Luo, X. B., Yang, L. Q., Luo, Z. L., & Zheng, P. M. (2012). The systematic classification of gallbladder stones. PloS one, 7(10), e48218.[Link][PubMed][DOI]
  4. Modha, K., & Navaneethan, U. (2015). Diagnosis and management of patients with obstructive jaundice. Cleveland Clinic Journal of Medicine, 82(2), 97-104.[Link][PubMed][DOI]
  5. Pavlovic Markovic, A., Stojkovic Lalosevic, M., Mijac, D. D., Milosavljevic, T., & Dumic, I. (2022). Jaundice as a Diagnostic and Therapeutic Problem: A General Practitioner's Approach. Digestive Diseases, 40(3), 362-369.[Link][PubMed][DOI]
  6. Roche, S. P., & Kobos, R. (2004). Jaundice in the adult patient. American Family Physician, 69(2), 299-304.[Link][PubMed]

Was this article helpful?

Frequently Asked Questions

How can I test my direct bilirubin at home?

You can test your direct bilirubin at home with SiPhox Health's Heart & Metabolic Program, which includes direct bilirubin testing along with other liver function markers. The Ultimate 360 Health Program also includes comprehensive liver testing with direct bilirubin, total bilirubin, and other essential liver enzymes.

What is the normal range for direct bilirubin?

Normal direct bilirubin levels typically range from 0.0 to 0.3 mg/dL. However, reference ranges may vary slightly between laboratories. Direct bilirubin should generally make up less than 20% of your total bilirubin. Values above 0.4 mg/dL or comprising more than 50% of total bilirubin may indicate a problem with bile flow.

Can high direct bilirubin levels return to normal?

Yes, direct bilirubin levels can return to normal once the underlying cause is treated. For example, if gallstones are causing the blockage, removing them typically results in rapid normalization of bilirubin levels. However, the timeline depends on the cause and severity of the obstruction. Some conditions may require ongoing management to maintain normal levels.

What's the difference between direct and indirect bilirubin?

Indirect bilirubin is the unconjugated form that's not water-soluble and hasn't been processed by the liver yet. Direct bilirubin is the conjugated form that has been processed by the liver and is water-soluble, ready for excretion through bile. High indirect bilirubin often indicates hemolysis or liver processing issues, while high direct bilirubin typically suggests problems with bile flow or excretion.

Are there any foods or supplements that can help lower direct bilirubin?

While no specific foods directly lower bilirubin levels, maintaining liver health through a balanced diet can support proper bilirubin processing. Foods rich in antioxidants, such as leafy greens, berries, and cruciferous vegetables, support liver function. Staying hydrated and limiting alcohol intake are also important. However, elevated direct bilirubin due to bile duct blockage requires medical treatment rather than dietary intervention alone.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details